Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02719353 · ClinicalTrials.gov registry record · NA

A Dispensing Clinical Trial of Comfilcon A Extended Range Multifocal Lenses

A NA study of Presbyopia, sponsored by CooperVision.

Completed
Registry status
NA
Development phase
14
Enrollment target
1
Study location

NCT02719353 is a NA study of Presbyopia that has completed, run by CooperVision. The registered enrollment target is 14 participants, below the 270-participant average among 38 other Presbyopia trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02719353, a NA study of Presbyopia, has completed, sponsored by CooperVision.

COMPLETED
Registry status
NA
Development phase
14 participants
Enrollment target
1
Study location

Study Summary

The aim of this study is to validate the clinical of comfilcon A extended range high add center near (CN) multifocal lenses in existing contact lens wearers against the current comfilcon A high add multifocal lenses.

Conditions Studied

Interventions

  • DEVICE comfilcon A Extended Range test lens
  • DEVICE comfilcon A control lens

Study Locations (1)

Indiana

  • CORL, Indiana University - Bloomington

Trial Details

FieldValue
Enrollment Target 14 participants
Start Date 2016-03
Est. Completion 2016-08
Phase NA

Sponsor

CooperVision

64 total trials

What the Registry Record Tells You About NCT02719353

The ClinicalTrials.gov registry entry for NCT02719353 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 270-participant average among 38 other Presbyopia trials with a reported enrollment target (95% lower). The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Presbyopia appearing as the primary indexed condition, and to 2 interventions - of which comfilcon A Extended Range test lens is the first listed.

NCT02719353 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.

Frequently Asked Questions

What is clinical trial NCT02719353 about?

NCT02719353 is a clinical study titled "A Dispensing Clinical Trial of Comfilcon A Extended Range Multifocal Lenses". The aim of this study is to validate the clinical of comfilcon A extended range high add center near (CN) multifocal lenses in existing contact lens wearers against the current comfilcon A high add multifocal lenses.

What is the current status of trial NCT02719353?

This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2016-03. Estimated completion is 2016-08.

What conditions does trial NCT02719353 study?

This clinical trial studies the following conditions: Presbyopia.

What interventions are being tested in trial NCT02719353?

The interventions under investigation include: comfilcon A Extended Range test lens (DEVICE), comfilcon A control lens (DEVICE).

Who is sponsoring clinical trial NCT02719353?

This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02719353 being conducted?

This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Presbyopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.